Table 1. Correlation between miR-3619-3p expression and clinicopathologic characteristics of PTC patients.
| Characteristics | miR-3619-3p | P value | |
|---|---|---|---|
| Low (%) | High (%) | ||
| Age (years) | 0.289 | ||
| <55 | 17 (94.4) | 15 (83.3) | |
| ≥55 | 1 (5.6) | 3 (16.7) | |
| Gender | 0.07 | ||
| Male | 3 (16.7) | 8 (44.4) | |
| Female | 15 (83.3) | 10 (55.6) | |
| Tumor size (cm) | 0.083 | ||
| <2 | 14 (77.8) | 9 (50.0) | |
| ≥2 | 4 (22.2) | 9 (50.0) | |
| Multicentricity | 0.044* | ||
| Negative | 13 (72.2) | 7 (38.9) | |
| Positive | 5 (27.8) | 11 (61.1) | |
| Extrathyroidal invasion | 0.011* | ||
| Negative | 9 (50.0) | 2 (11.1) | |
| Positive | 9 (50.0) | 16 (88.9) | |
| Lymphatic metastasis | 0.026* | ||
| Negative | 8 (44.4) | 2 (11.1) | |
| Positive | 10 (55.6) | 16 (88.9) | |
| TNM stage | 0.289 | ||
| I | 17 (94.4) | 15 (83.3) | |
| II | 1 (5.6) | 3 (16.7) | |
The TNM stage is based on the Eighth Edition of the AJCC TNM Staging System of differentiated thyroid cancer. *, P values <0.05 indicate statistical significance. PTC, papillary thyroid carcinoma; AJCC, American Joint Committee on Cancer.